Riskpilot← Back to searchSign inGet full accessAoptik i Alvesta AB
ABActiveOrg 5568438617Järnvägsparken 3 ARetail sale of medical and orthopaedic goods · NACE 4774Est. 20112 employees
Revenue 2025
SEK 5,3M
-7% vs 2024
EBITDA margin
13.1%
-56% vs 2024
Equity ratio
44.6%
Financial strength
Net profit 2025
SEK 566K
-55% vs 2024
| Revenue | SEK 5,3M | -7% |
| EBITDA | SEK 694K | -56% |
| Net profit | SEK 566K | -55% |
| Total assets | SEK 1,6M | -36% |
| Equity | SEK 695K | -51% |
| Employees | 2 | — |
Legal name
Aoptik i Alvesta AB
Org number
5568438617
Legal form
Aktiebolag
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
1 mars 2011
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva optiker- verksamhet såsom handel med glasögon, linser, optiska artiklar och därmed förenlig verksamhet.
Address
Järnvägsparken 3 A
Phone
+46707775355
Email
johan.olofsson@aoptik.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6 583 | 6 133 | 5 298 | 5 709 | 5 292 |
| Staff expenses | — | — | — | — | −2 468 |
| EBITDA | 2 917 | 2 861 | 3 086 | 1 569 | 694 |
| Depreciation & amort. | −45 | −37 | −37 | −15 | — |
| EBIT | 2 872 | 2 824 | 3 049 | 1 554 | 694 |
| Net financials | 18 | 43 | 42 | 18 | 19 |
| Profit before tax | 2 897 | 2 876 | 3 101 | 1 571 | 713 |
| Tax | −622 | −595 | −640 | −326 | −146 |
| Net profit | 2 275 | 2 281 | 2 461 | 1 245 | 566 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 748 | 5 689 | 3 351 | 2 446 | 1 557 |
| Equity | 3 841 | 4 622 | 2 583 | 1 429 | 695 |
| Long-term debt | 444 | 338 | 338 | 338 | 0 |
| Short-term debt | 443 | 718 | 430 | 679 | 862 |
| Total debt | 887 | 1 056 | 768 | 1 017 | 862 |
EBITDA margin
13.1%
This company
15.8%
Market median
-17% vs market
20212025
Equity ratio
44.6%
This company
38.2%
Market median
+17% vs market
20212025
Return on equity
81.5%
This company
18.4%
Market median
+343% vs market
20212025
Net profit margin
10.7%
This company
8.1%
Market median
+32% vs market
20212025
Asset turnover
3.40×
This company
1.12×
Market median
+204% vs market
20212025
Debt / equity
1.24×
This company
0.62×
Market median
-100% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PR Auditor Substitute | Auditor Substitute | 2022 |
| Audit | 2022 | |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ettöringen AB
Aoptik i Alvesta AB Board members of Aoptik i Alvesta AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Rikard Johelid | Auditor Substitute | 0 companies |
| Carl-Peter Bertil Kalle Wrane | Audit | 0 companies |
| Johan Gunnar Bylund | Deputy Board Member | 0 companies |
| Ann-Sofi Lilian Andersson | Deputy Board Member | 0 companies |
| Per Johan Olofsson | Board of Directors | 0 companies |